ULTRATRACE ANALYSIS OF DNA LESIONS WITH ELECTROPHORES
使用电泳仪对 DNA 损伤进行超微量分析
基本信息
- 批准号:3173387
- 负责人:
- 金额:$ 18.03万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1983
- 资助国家:美国
- 起止时间:1983-09-01 至 1989-08-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
The goal of this project is to quantitate DNA adducts in human samples by
gas chromatography with electron capture detection (GC-ECD) and with
detection by negative chemical ionization mass spectrometry (GC-NCI-MS).
High sensitivity is obtained by labeling the adducts with electrophores.
For standards of pyrimidine bases and nucleosides, detection limits at the
low fg level are currently observed. Overall the methodology consists of
the following steps: (1) purification of the DNA; (2) hydrolysis (acid or
enzymes) of the DNA down to DNA monomers; (3) separation of lesion (damage)
from normal DNA monomers by high performance liquid chromatography (HPLC);
and either (4a) chemical labeling of the lesion monomers with "direct
electrophores", followed by characterization and quantitation of these
electrophore-labeled monomers by GC-ECD/GC-NICI-MS, or (4b) chemical
labeling of the lesion monomers with "release tag electrophores", followed
by characterization using HPLC and quantitation by GC-ECD. First the
methodology will be applied, including ongoing work, to several alkyl
adducts: O6-alkyl-guanine, O4-alkyl-thymine, O2-alkyl-thymine, and
O2-alkyl-cytosine. Next the corresponding hydroxyethyl adducts anticipated
to arise from exposure to ethylene oxide will be determined. Finally
N6-hydroxymethyl-adenine and protein-(lysyl)-nucleoside will be determined
as potential adducts caused by exposure to formaldehyde. This research is
needed to help determine the carcinogenic and mutagenic risks of human
exposure to chemicals.
该项目的目标是通过以下方式定量人体样本中的DNA加合物
气相色谱-电子捕获检测器(GC-ECD)和
通过负化学电离质谱法(GC-NCI-MS)检测。
通过用双标记物标记加合物获得高灵敏度。
对于嘧啶碱基和核苷的标准品,
目前观察到低FG水平。 总体而言,该方法包括
以下步骤:(1)纯化DNA;(2)水解(酸或
(3)分离损伤(损伤)
通过高效液相色谱(HPLC)从正常DNA单体;
或者(4a)用“直接”标记的损伤单体的化学标记
这些化合物的表征和定量
通过GC-ECD/GC-NICI-MS法测定的三聚体标记单体,或(4 b)化学
用“释放标签标记物”标记病变单体,
通过HPLC表征和GC-ECD定量。 首先
将采用的方法,包括正在进行的工作,
加合物:O 6-烷基-鸟嘌呤,O 4-烷基-胸腺嘧啶,O2-烷基-胸腺嘧啶,和
O2-烷基-胞嘧啶。 接下来,预期相应的羟乙基加合物
将确定暴露于环氧乙烷引起的风险。 最后
将测定N6-羟甲基-腺嘌呤和蛋白质-(赖氨酰)-核苷
可能是由于接触甲醛而产生的加合物。 本研究是
需要帮助确定人类的致癌和致突变风险,
暴露于化学物质。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ROGER Wallace GIESE其他文献
ROGER Wallace GIESE的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ROGER Wallace GIESE', 18)}}的其他基金
Project 3: Discovery of Xenobiotics Associated with Preterm Birth
项目3:与早产相关的异生素的发现
- 批准号:
8884316 - 财政年份:2010
- 资助金额:
$ 18.03万 - 项目类别:
Project 3: Discovery of Xenobiotics Associated with Preterm Birth
项目3:与早产相关的异生素的发现
- 批准号:
8831684 - 财政年份:2010
- 资助金额:
$ 18.03万 - 项目类别:
Project 3: Discovery of Xenobiotics Associated with Preterm Birth
项目3:与早产相关的异生素的发现
- 批准号:
8927935 - 财政年份:2010
- 资助金额:
$ 18.03万 - 项目类别:
Project 3: Discovery of Xenobiotics Associated with Preterm Birth
项目3:与早产相关的异生素的发现
- 批准号:
8649397 - 财政年份:2010
- 资助金额:
$ 18.03万 - 项目类别:
Project 3: Discovery of Xenobiotics Associated with Preterm Birth
项目3:与早产相关的异生素的发现
- 批准号:
9249553 - 财政年份:2010
- 资助金额:
$ 18.03万 - 项目类别:
Project 1: Discovery of Xenobiotics Associated with Preterm Birth
项目1:与早产相关的异生素的发现
- 批准号:
7936551 - 财政年份:2010
- 资助金额:
$ 18.03万 - 项目类别:
Discovery of Genotoxic Biomarkers in Urine for Cancer
尿液中癌症基因毒性生物标志物的发现
- 批准号:
6743420 - 财政年份:2003
- 资助金额:
$ 18.03万 - 项目类别:
Discovery of Genotoxic Biomarkers in Urine for Cancer
尿液中癌症基因毒性生物标志物的发现
- 批准号:
6803564 - 财政年份:2003
- 资助金额:
$ 18.03万 - 项目类别:
相似海外基金
Prevention of Radiation-Induced Carcinogenesis by Senolytics
通过 Senolytics 预防辐射诱发的致癌作用
- 批准号:
23H03539 - 财政年份:2023
- 资助金额:
$ 18.03万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Elucidation of Prostaglandin D Receptor-mediated Carcinogenesis Mechanism of Colitic Cancer
前列腺素D受体介导的结肠癌致癌机制的阐明
- 批准号:
23K08219 - 财政年份:2023
- 资助金额:
$ 18.03万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Molecular mechanisms of carcinogenesis and symptoms associated with alcohol consumption
致癌的分子机制和饮酒相关症状
- 批准号:
23K05734 - 财政年份:2023
- 资助金额:
$ 18.03万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
The mechanism of oral carcinogenesis by FAT1 gene mutation
FAT1基因突变导致口腔癌的机制
- 批准号:
23K15977 - 财政年份:2023
- 资助金额:
$ 18.03万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Interactions Between the Microbiota and Helicobacter pylori in Gastric Carcinogenesis
微生物群与幽门螺杆菌在胃癌发生中的相互作用
- 批准号:
10709135 - 财政年份:2023
- 资助金额:
$ 18.03万 - 项目类别:
Pathways of Injury and Repair in Barrett's Carcinogenesis
巴雷特癌发生过程中的损伤和修复途径
- 批准号:
10713938 - 财政年份:2023
- 资助金额:
$ 18.03万 - 项目类别:
Spatial transcriptomic research on carcinogenesis and progression of lung cancer with interstitial pneumonia
肺癌合并间质性肺炎发生发展的空间转录组学研究
- 批准号:
23K14468 - 财政年份:2023
- 资助金额:
$ 18.03万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
TWINNING FOR EXCELLENCE TO STRATEGICALLY ADVANCE RESEARCH IN CARCINOGENESIS AND CANCER
结对卓越,战略性地推进致癌和癌症研究
- 批准号:
10050740 - 财政年份:2023
- 资助金额:
$ 18.03万 - 项目类别:
EU-Funded
Mechanisms of myeloid cell driven pancreatic plasticity and carcinogenesis
骨髓细胞驱动胰腺可塑性和致癌机制
- 批准号:
10607213 - 财政年份:2023
- 资助金额:
$ 18.03万 - 项目类别:














{{item.name}}会员




